Palo Alto, CA, United States of America

Guriqbal Basi

USPTO Granted Patents = 14 

Average Co-Inventor Count = 7.7

ph-index = 7

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2003-2015

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Guriqbal Basi: Innovator in Antibody Research

Introduction

Guriqbal Basi is a prominent inventor based in Palo Alto, California, known for his significant contributions to the field of antibody research. With a total of 14 patents to his name, Basi has made remarkable strides in developing innovative solutions for various medical challenges.

Latest Patents

Among his latest patents, Basi has developed hybrid amyloid-beta antibodies. This invention provides crystals that include amino acids 1-7 of SEQ ID NO:1 and a Fab fragment of 12A11, 12B4, 10D5, or 3D6. Additionally, it encompasses amino acids 1-40 of SEQ ID NO:1 and a Fab fragment of 12A11 or 3D6. The invention also outlines methods for preparing these crystals. Furthermore, Basi has introduced a computer-implemented method for analyzing the binding of a candidate antibody fragment to a peptide that includes an epitope of amino acids 1-7 of SEQ ID NO:1. This includes methods for identifying antibody fragments that can mimic the Fab fragments of 12A11 and 3D6, as well as designing humanized antibodies that bind to specific peptides.

Another significant patent focuses on alpha-synuclein kinase. This invention provides agents and methods for treating diseases associated with Lewy body diseases (LBDs) in the brain. Preferred agents include inhibitors of PLK2 kinase, showcasing Basi's commitment to addressing critical health issues.

Career Highlights

Throughout his career, Guriqbal Basi has worked with notable companies such as Elan Pharmaceuticals, Inc. and Elan Pharma International Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Basi has collaborated with esteemed colleagues, including John P. Anderson and Sukanto Sinha. These partnerships have likely enhanced his research and development efforts, leading to innovative breakthroughs in antibody technology.

Conclusion

Guriqbal Basi stands out as a leading inventor in the realm of antibody research, with a strong portfolio of patents that address significant medical challenges. His work continues to influence the field and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…